Search for "racemisation" in Full Text gives 24 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2025, 21, 1808–1853, doi:10.3762/bjoc.21.143
Graphical Abstract
Figure 1: Energy diagram of a two-state photoswitch. Figure 1 was redrawn from [2].
Figure 2: Example of the absorption spectra of the isomers of a photoswitch with most efficient irradiation w...
Scheme 1: Photoswitch classes described in this review.
Figure 3: Azoheteroarenes.
Scheme 2: E–Z Isomerisation (top) and mechanisms of thermal Z–E isomerisation (bottom).
Scheme 3: Rotation mechanism favoured by the electron displacement in push–pull systems. Selected examples of...
Figure 4: A) T-shaped and twisted Z-isomers determine the thermal stability and the Z–E-PSS (selected example...
Figure 5: Effect of di-ortho-substitution on thermal half-life and PSS.
Figure 6: Selected thermal lifetimes of azoindoles in different solvents and concentrations. aConcentration o...
Figure 7: Aryliminopyrazoles: N-pyrazoles (top) and N-phenyl (bottom).
Scheme 4: Synthesis of symmetrical heteroarenes through oxidation (A), reduction (B), and the Bayer–Mills rea...
Scheme 5: Synthesis of diazonium salt (A); different strategies of azo-coupling: with a nucleophilic ring (B)...
Scheme 6: Synthesis of arylazothiazoles 25 (A) and heteroaryltriazoles 28 (B).
Scheme 7: Synthesis of heteroarylimines 31a,b [36-38].
Figure 8: Push–pull non-ionic azo dye developed by Velasco and co-workers [45].
Scheme 8: Azopyridine reported by Herges and co-workers [46].
Scheme 9: Photoinduced phase transitioning azobispyrazoles [47].
Figure 9: Diazocines.
Scheme 10: Isomers, conformers and enantiomers of diazocine.
Scheme 11: Partial overlap of the ππ* band with electron-donating substituents and effect on the PSS. Scheme 11 was ada...
Figure 10: Main properties of diazocines with different bridges. aMeasured in n-hexane [56]. bMeasured in THF. cMe...
Scheme 12: Synthesis of symmetric diazocines.
Scheme 13: Synthesis of asymmetric diazocines.
Scheme 14: Synthesis of O- and S-heterodiazocines.
Scheme 15: Synthesis of N-heterodiazocines.
Scheme 16: Puromycin diazocine photoswitch [60].
Figure 11: Indigoids.
Figure 12: The main representatives of the indigoid photoswitch class.
Scheme 17: Deactivation process that prevents Z-isomerisation of indigo.
Figure 13: Stable Z-indigo derivative synthesised by Wyman and Zenhäusern [67].
Figure 14: Selected examples of indigos with aliphatic and aromatic substituents [68]. Dashed box: proposed π–π in...
Scheme 18: Resonance structures of indigo and thioindigo involving the phenyl ring.
Scheme 19: Possible deactivation mechanism for 4,4'-dihydroxythioindigo [76].
Scheme 20: Effect of different heteroaryl rings on the stability and the photophysical properties of hemiindig...
Figure 15: Thermal half-lives of red-shifted hemithioindigos in toluene [79]. aMeasured in toluene-d8.
Scheme 21: Structures of pyrrole [81] and imidazole hemithioindigo [64].
Figure 16: Examples of fully substituted double bond hemithioindigo (left), oxidised hemithioindigos (centre),...
Scheme 22: Structure of iminothioindoxyl 72 (top) and acylated phenyliminoindolinone photoswitch 73 (bottom). ...
Scheme 23: (top) Transition states of iminothioindoxyl 72. The planar transition state is associated with a lo...
Scheme 24: Baeyer–Drewsen synthesis of indigo (top) and N-functionalisation strategies (bottom).
Scheme 25: Synthesis of hemiindigo.
Scheme 26: Synthesis of hemithioindigo and iminothioindoxyl.
Scheme 27: Synthesis of double-bond-substituted hemithioindigos.
Scheme 28: Synthesis of phenyliminoindolinone.
Scheme 29: Hemithioindigo molecular motor [85].
Figure 17: Arylhydrazones.
Scheme 30: Switching of arylhydrazones. Note: The definitions of stator and rotor are arbitrary.
Scheme 31: Photo- and acidochromism of pyridine-based phenylhydrazones.
Scheme 32: A) E–Z thermal inversion of a thermally stable push–pull hydrazone [109]. B) Rotation mechanism favoured...
Scheme 33: Effect of planarisation on the half-life.
Scheme 34: The longest thermally stable hydrazone switches reported so far (left). Modulation of thermal half-...
Figure 18: Dependency of t1/2 on concentration and hypothesised aggregation-induced isomerisation.
Figure 19: Structure–property relationship of acylhydrazones.
Scheme 35: Synthesis of arylhydrazones.
Scheme 36: Synthesis of acylhydrazones.
Scheme 37: Photoswitchable fluorophore by Aprahamian et al. [115].
Scheme 38: The four-state photoswitch synthesised by the Cigáň group [116].
Figure 20: Diarylethenes.
Scheme 39: Isomerisation and oxidation pathway of E-stilbene to phenanthrene.
Scheme 40: Strategies adapted to avoid E–Z isomerisation and oxidation.
Scheme 41: Molecular orbitals and mechanism of electrocyclisation for a 6π system.
Figure 21: Aromatic stabilisation energy correlated with the thermal stability of the diarylethenes [127,129].
Figure 22: Half-lives of diarylethenes with increasing electron-withdrawing groups [128,129].
Scheme 42: Photochemical degradation pathway promoted by electron-donating groups [130].
Figure 23: The diarylethenes studied by Hanazawa et al. [134]. Increased rigidity leads to bathochromic shift.
Scheme 43: The dithienylethene synthesised by Nakatani's group [135].
Scheme 44: Synthesis of perfluoroalkylated diarylethenes.
Scheme 45: Synthesis of 139 and 142 via McMurry coupling.
Scheme 46: Synthesis of symmetrical derivatives 145 via Suzuki–Miyaura coupling.
Scheme 47: Synthesis of acyclic 148, malonic anhydride 149, and maleimide derivatives 154.
Figure 24: Gramicidin S (top left) and two of the modified diarylethene derivatives: first generation (bottom ...
Scheme 48: Pyridoxal 5'-phosphate and its reaction with an amino acid (top). The analogous dithienylethene der...
Figure 25: Fulgides.
Scheme 49: The three isomers of fulgides.
Scheme 50: Thermal and photochemical side products of unsubstituted fulgide [150].
Figure 26: Maximum absorption λc of the closed isomer compared with the nature of the aromatic ring and the su...
Scheme 51: Possible rearrangement of the excited state of 5-dimethylaminoindolylfulgide [153].
Figure 27: Quantum yields of ring closure (ΦE→C) and E–Z isomerisation (ΦE→Z) correlated with the increasing s...
Scheme 52: Active (Eα) and inactive (Eβ) conformers (left) and the bicyclic sterically blocked fulgide 169 (ri...
Scheme 53: Quantum yield of ring-opening (ΦC→E) and E–Z isomerisation (ΦE→Z) for different substitution patter...
Scheme 54: Stobbe condensation pathway for the synthesis of fulgides 179, fulgimides 181 and fulgenates 178.
Scheme 55: Alternative synthesis of fulgides through Pd-catalysed carbonylation.
Scheme 56: Optimised synthesis of fulgimides [166].
Scheme 57: Photoswitchable FRET with a fulgimide photoswitch [167].
Scheme 58: Three-state fulgimide strategy by Slanina's group.
Figure 28: Spiropyrans.
Scheme 59: Photochemical (left) and thermal (right) ring-opening mechanisms for an exemplary spiropyran with a...
Figure 29: Eight possible isomers of the open merocyanine according to the E/Z configurations of the bonds hig...
Scheme 60: pH-Controlled photoisomerisation between the closed spiropyran 191-SP and the open E-merocyanine 19...
Scheme 61: Behaviour of spiropyran in water buffer according to Andréasson and co-workers [180]. 192-SP in an aqueo...
Scheme 62: (left box) Proposed mechanism of basic hydrolysis of MC [184]. (right box) Introduction of electron-dona...
Scheme 63: Photochemical interconversion of naphthopyran 194 (top) and spirooxazine 195 (bottom) photoswitches...
Scheme 64: Synthesis of spiropyrans and spirooxazines 198 and the dicondensation by-product 199.
Scheme 65: Alternative synthesis of spiropyrans and spirooxazines with indolenylium salt 200.
Scheme 66: Synthesis of 4’-substituted spiropyrans 203 by condensation of an acylated methylene indoline 201 w...
Scheme 67: Synthesis of spironaphthopyrans 210 by acid-catalysed condensation of naphthols and diarylpropargyl...
Scheme 68: Photoswitchable surface wettability [194].
Figure 30: Some guiding principles for the choice of the most suitable photoswitch. Note that this guide is ve...
Beilstein J. Org. Chem. 2025, 21, 1324–1373, doi:10.3762/bjoc.21.101
Graphical Abstract
Figure 1: Bond lengths and bond angles in oxetane at 140 K [2].
Figure 2: Analogy of 3-substituted oxetanes to carbonyl and gem-dimethyl groups [12].
Figure 3: Use of oxetanes in drug design – selected examples.
Figure 4: Examples of oxetane-containing natural products.
Scheme 1: Synthetic strategies towards construction of the oxetane ring.
Scheme 2: Overview of intramolecular Williamson etherification and competing Grob fragmentation.
Scheme 3: Synthesis of spiro-oxetanes via 1,4-C–H insertion and Williamson etherification.
Scheme 4: Use of phenyl vinyl selenone in the synthesis of spirooxindole oxetanes.
Scheme 5: Synthesis of bicyclic 3,5-anhydrofuranoses via double epoxide opening/etherification.
Scheme 6: Preparation of spirooxetanes by cycloisomerisation via MHAT/RPC.
Scheme 7: Oxetane synthesis via alcohol C–H functionalisation.
Scheme 8: Access to oxetanes 38 from α-acetyloxy iodides.
Scheme 9: The kilogram-scale synthesis of oxetane intermediate 41.
Scheme 10: Overview of the intramolecular opening of 3-membered rings.
Scheme 11: Synthesis of 4,7-dioxatricyclo[3.2.1.03,6]octane skeletons.
Scheme 12: Silicon-directed electrophilic cyclisation of homoallylic alcohols.
Scheme 13: Hydrosilylation–iodocyclisation of homopropargylic alcohols.
Scheme 14: Cu-catalysed intramolecular O-vinylation of γ-bromohomoallylic alcohols.
Scheme 15: Cu-catalysed intramolecular cross-coupling of hydroxyvinylstannanes.
Scheme 16: Isomerisation of oxiranyl ethers containing weakly carbanion-stabilising groups.
Scheme 17: Cyclisation of diethyl haloalkoxymalonates.
Scheme 18: Synthesis of oxetanes through a 1,5-HAT/radical recombination sequence.
Scheme 19: General approach to oxetanes via [2 + 2] cycloadditions.
Scheme 20: Synthesis of tricyclic 4:4:4 oxetanes through a photochemical triple cascade reaction.
Scheme 21: Iridium-catalysed Paternò–Büchi reaction between α-ketoesters and simple alkenes.
Scheme 22: Three-step synthesis of spirocyclic oxetanes 83 via Paternò–Büchi reaction, nucleophilic ring openi...
Scheme 23: Enantioselective Paternò–Büchi reaction catalysed by a chiral iridium photocatalyst.
Scheme 24: Synthesis of polysubstituted oxetanes 92 via Cu(II)-mediated formal [2 + 2] cycloadditions.
Scheme 25: Synthesis of alkylideneoxetanes via NHC- and DBU-mediated formal [2 + 2] cycloadditions.
Scheme 26: Use of sulphur-stabilised carbanions in ring expansions.
Scheme 27: Synthesis of α,α-difluoro(arylthio)methyl oxetanes.
Scheme 28: Ring expansion in an industrial synthesis of PF-06878031.
Scheme 29: Ring contraction of triflated 2-hydroxy-γ-lactones.
Scheme 30: Ring contraction in an industrial synthesis of PF-06878031.
Scheme 31: Photochemical ring contraction of 2,5-dihydrofurans by aryldiazoacetic acid esters.
Scheme 32: Synthesis of 3-oxetanones via O-H insertion of carbenes.
Scheme 33: Synthesis of phosphonate oxetanones via gold-mediated alkyne oxidation/O–H insertion.
Scheme 34: Syntheses and common derivatisations of 3-oxetanone.
Scheme 35: SN1 substitution of 3-aryloxetan-3-ols by thiols and alcohols.
Scheme 36: Fe–Ni dual-catalytic olefin hydroarylation towards 3-alkyl-3-(hetero)aryloxetanes.
Scheme 37: Synthesis of 3-aryloxetan-3-carboxylic acids.
Scheme 38: Decarboxylative alkylation of 3-aryloxetan-3-carboxylic acids.
Scheme 39: Synthesis of 3-amino-3-aryloxetanes via photoredox/nickel cross-coupling catalysis.
Scheme 40: Intermolecular cross-selective [2 + 2] photocycloaddition towards spirooxetanes.
Scheme 41: Synthesis of 3-aryl-3-aminooxetanes via defluorosulphonylative coupling.
Scheme 42: Two-step synthesis of amide bioisosteres via benzotriazolyl Mannich adducts 170.
Scheme 43: Functionalisation of oxetanyl trichloroacetimidates 172.
Scheme 44: Synthesis of oxetane-amino esters 176.
Scheme 45: Tandem Friedel–Crafts alkylation/intramolecular ring opening of 3-aryloxetan-3-ols.
Scheme 46: Synthesis of polysubstituted furans and pyrroles.
Scheme 47: Synthesis of oxazolines and bisoxazolines.
Scheme 48: Tandem, one-pot syntheses of various polycyclic heterocycles.
Scheme 49: Synthesis of 1,2-dihydroquinolines via skeletal reorganisation of oxetanes.
Scheme 50: Synthesis of benzoindolines and 2,3-dihydrobenzofurans and their derivatisations.
Scheme 51: Synthesis of polysubstituted 1,4-dioxanes.
Scheme 52: Preparation of various lactones via ring opening of oxetane-carboxylic acids 219.
Scheme 53: Tsuji-Trost allylation/ring opening of 3-aminooxetanes.
Scheme 54: Arylative skeletal rearrangement of 3-vinyloxetan-3-ols to 2,5-dihydrofurans.
Scheme 55: Reductive opening of oxetanes using catalytic Mg–H species.
Scheme 56: Opening of oxetanes by silyl ketene acetals.
Scheme 57: Rhodium-catalysed hydroacylation of oxetanes.
Scheme 58: Generation of radicals from oxetanes mediated by a vitamin B12-derived cobalt catalyst.
Scheme 59: Reductive opening of oxetanes by B–Si frustrated Lewis pairs.
Scheme 60: Zirconocene-mediated reductive opening of oxetanes.
Scheme 61: Enantioselective syntheses of small and medium-size rings using chiral phosphoric acids.
Scheme 62: Asymmetric synthesis of 2,3-dihydrobenzo[b]oxepines catalysed by a chiral scandium complex.
Scheme 63: Enantioselective synthesis of 1,3-bromohydrins under a chiral squaramide catalysis.
Scheme 64: Enantioselective opening of 2-aryl-2-ethynyloxetanes by anilines.
Scheme 65: Ru-catalysed insertion of diazocarbonyls into oxetanes.
Scheme 66: Ring expansion of oxetanes by stabilised carbenes generated under blue light irradiation.
Scheme 67: Expansion of oxetanes via nickel-catalysed insertion of alkynyltrifluoroborates.
Scheme 68: Nickel-catalysed expansion of oxetanes into ε-caprolactones.
Scheme 69: Expansion of oxetanes via cobalt-catalysed carbonyl insertion.
Scheme 70: Gold-catalysed intramolecular 1,1-carboalkoxylation of oxetane-ynamides.
Scheme 71: Expansion of oxetanes by stabilised sulphoxonium ylides.
Scheme 72: Cu-catalysed ring expansion of 2-vinyloxetanes by diazoesters.
Scheme 73: Total synthesis of (+)-oxetin.
Scheme 74: Total synthesis of racemic oxetanocin A.
Scheme 75: Total synthesis of (−)-merrilactone A.
Scheme 76: Total synthesis of (+)-dictyoxetane.
Scheme 77: Total synthesis of ent-dichrocephone B.
Scheme 78: Total synthesis of (−)-mitrephorone A.
Scheme 79: Total synthesis of (−)-taxol.
Beilstein J. Org. Chem. 2024, 20, 1652–1670, doi:10.3762/bjoc.20.147
Graphical Abstract
Figure 1: Schematic representation of the different acceptor regions for the methylation of RiPPs discussed i...
Figure 2: Schematic overview of different methylation strategies for amino acids and peptides. There are seve...
Figure 3: Biological methylation. A) Methyl donors from biological systems. The transferred methyl group is h...
Figure 4: Chemical structures of RiPPs with diverse O-, N-, C-, and S-methylations. Amino acids of lassomycin...
Figure 5: The three-dimensional structures of the conventional O-MTs OlvSA (model structure calculated by Col...
Figure 6: Reaction scheme of the PAMT´s catalysis, leading to the enzymatic conversion of aspartate to aspart...
Figure 7: Structural organisation of the OphMA homodimer. A) Schematic representation. The MT domain is colou...
Figure 8: Overview of the protein architectures and core peptide compositions of borosin N-MTs as defined by ...
Figure 9: Radical SAM C-methyltransferases. A) The different rSAM MT classes containing different functional ...
Figure 10: The three-dimensional structures of the rSAM C-MTs TsrM with bound cobalamin and [4Fe-4S] cluster (...
Beilstein J. Org. Chem. 2024, 20, 1088–1098, doi:10.3762/bjoc.20.96
Graphical Abstract
Figure 1: A) Deamination of cytosine, dC and C as individual nucleosides or as part of a polynucleotide chain...
Scheme 1: i) Boc2O, DMAP, THF, rt, overnight; ii) aq 5 M NaOH, rt, 3 h, 89% yield over two steps; iii) 3, azo...
Scheme 2: i) NaN3, n-Bu4NHSO4, NaHCO3/CHCl3 (1:1), rt, 20 min, 88% yield; ii) a) H2, Pd/C, CH2Cl2, rt, 3 h; b...
Scheme 3: i) H2, 5% Pd/CaCO3/3% Pb, Et3N, CH2Cl2, rt, 1.5 h, 34% and 21% yield for α- and β-anomer of 18, res...
Figure 2: V0 of A3A mimic-catalysed deamination of 5'-dTTTTCAT in the absence (no inhibitor) and presence of ...
Beilstein J. Org. Chem. 2024, 20, 921–930, doi:10.3762/bjoc.20.82
Graphical Abstract
Figure 1: Advantages of acyl fluorides compared to acyl chlorides, previous work on BT-SRF reagents [29-33] and a su...
Scheme 1: Scope of the BT-SCF3-mediated deoxygenative fluorination of carboxylic acids 1. Reactions were perf...
Scheme 2: Scope of the one-pot BT-SCF3-mediated deoxygenative coupling of carboxylic acids and amines via acy...
Scheme 3: One-pot BT-SCF3-mediated deoxygenative coupling of amino acids. Isolated yields after column chroma...
Scheme 4: Plausible mechanism for the deoxyfluorination of carboxylic acids with BT-SCF3.
Scheme 5: Mechanistic experiments. (a) Conversion of thioester 3a into acyl fluoride 2a in the presence of DI...
Beilstein J. Org. Chem. 2022, 18, 1159–1165, doi:10.3762/bjoc.18.120
Graphical Abstract
Scheme 1: Structures of hangtaimycin (1) and its co-metabolites.
Scheme 2: First synthetic route towards TDD (4).
Figure 1: HPLC analyses of (Z)-4 on a chiral stationary phase. A) Nearly racemic 4 from the first synthetic r...
Scheme 3: Second synthetic route towards TDD ((Z)-4).
Figure 2: X-ray structure of (rac)-4.
Figure 3: Bioactivity testing with hangtaimycin (1). A) Growth retardation of model species B. subtilis 168 a...
Beilstein J. Org. Chem. 2022, 18, 167–173, doi:10.3762/bjoc.18.18
Graphical Abstract
Figure 1: Model of the catalyst action.
Figure 2: Catalysts screened.
Scheme 1: Screening of different N-protecting groups. Reaction conditions: 0.2 M solution of 1 (1 equiv), 2 (...
Scheme 2: Scope of the reaction (the relative configuration of the major diastereoisomer is depicted). Reacti...
Scheme 3: Comparison reactions of E- and Z-isomers (the relative configurations of the major diastereoisomers...
Beilstein J. Org. Chem. 2021, 17, 873–884, doi:10.3762/bjoc.17.73
Graphical Abstract
Scheme 1: Kinetic mechanisms. In each case E represents the free enzyme, other species starting E are other e...
Figure 1: Reaction progress for “ordered, second” kinetics and the effect of D/Q (e.g., NADH/NAD+) ratio. S0 ...
Figure 2: Effect of the initial starting material concentration and enzyme E value for “ordered, second” kine...
Figure 3: Effects of key enzyme parameters on the fall in product ee during reaction for “ordered, second” ki...
Figure 4: Reaction progress for “ping-pong, second” kinetics, and the effect of the ratio of donor to prochir...
Figure 5: Effect of the key ee decline parameter (eeDP) of the enzyme on the product ee for “ping-pong, secon...
Figure 6: Effects of prochiral substrate concentration and its KM value for “ping-pong, first” kinetics. Inpu...
Figure 7: Effect of eeDP and k−4 · Keq/k4 on the product ee at high conversion for “ping-pong, first” kinetic...
Figure 8: Progress curves for “ping-pong, both” kinetics, diacid esterification. The plot shows the increasin...
Figure 9: Effects on the ee of the product formed early in the reaction for “ping-pong, both” kinetics, diaci...
Figure 10: Increase in the product ee as the reaction proceeds for “ping-pong, both” kinetics, diacid esterifi...
Figure 11: Effects on the ee at high conversion for diacid ester synthesis, “ping-pong, both” kinetics. Parame...
Beilstein J. Org. Chem. 2020, 16, 2363–2441, doi:10.3762/bjoc.16.197
Graphical Abstract
Scheme 1: Amine/photoredox-catalysed α-alkylation of aldehydes with alkyl bromides bearing electron-withdrawi...
Scheme 2: Amine/HAT/photoredox-catalysed α-functionalisation of aldehydes using alkenes.
Scheme 3: Amine/cobalt/photoredox-catalysed α-functionalisation of ketones and THIQs.
Scheme 4: Amine/photoredox-catalysed α-functionalisation of aldehydes or ketones with imines. (a) Using keton...
Scheme 5: Bifunctional amine/photoredox-catalysed enantioselective α-functionalisation of aldehydes.
Scheme 6: Bifunctional amine/photoredox-catalysed α-functionalisation of aldehydes using amine catalysts via ...
Scheme 7: Amine/photoredox-catalysed RCA of iminium ion intermediates. (a) Synthesis of quaternary stereocent...
Scheme 8: Bifunctional amine/photoredox-catalysed RCA of enones in a radical chain reaction initiated by an i...
Scheme 9: Bifunctional amine/photoredox-catalysed RCA reactions of iminium ions with different radical precur...
Scheme 10: Bifunctional amine/photoredox-catalysed radical cascade reactions between enones and alkenes with a...
Scheme 11: Amine/photocatalysed photocycloadditions of iminium ion intermediates. (a) External photocatalyst u...
Scheme 12: Amine/photoredox-catalysed addition of acrolein (94) to iminium ions.
Scheme 13: Dual NHC/photoredox-catalysed acylation of THIQs.
Scheme 14: NHC/photocatalysed spirocyclisation via photoisomerisation of an extended Breslow intermediate.
Scheme 15: CPA/photoredox-catalysed aza-pinacol cyclisation.
Scheme 16: CPA/photoredox-catalysed Minisci-type reaction between azaarenes and α-amino radicals.
Scheme 17: CPA/photoredox-catalysed radical additions to azaarenes. (a) α-Amino radical or ketyl radical addit...
Scheme 18: CPA/photoredox-catalysed reduction of azaarene-derived substrates. (a) Reduction of ketones. (b) Ex...
Scheme 19: CPA/photoredox-catalysed radical coupling reactions of α-amino radicals with α-carbonyl radicals. (...
Scheme 20: CPA/photoredox-catalysed Povarov reaction.
Scheme 21: CPA/photoredox-catalysed reactions with imines. (a) Decarboxylative imine generation followed by Po...
Scheme 22: Bifunctional CPA/photocatalysed [2 + 2] photocycloadditions.
Scheme 23: PTC/photocatalysed oxygenation of 1-indanone-derived β-keto esters.
Scheme 24: PTC/photoredox-catalysed perfluoroalkylation of 1-indanone-derived β-keto esters via a radical chai...
Scheme 25: Bifunctional hydrogen bonding/photocatalysed intramolecular [2 + 2] photocycloadditions of quinolon...
Scheme 26: Bifunctional hydrogen bonding/photocatalysed intramolecular RCA cyclisation of a quinolone.
Scheme 27: Bifunctional hydrogen bonding/photocatalysed intramolecular [2 + 2] photocycloadditions of quinolon...
Scheme 28: Bifunctional hydrogen bonding/photocatalysed [2 + 2] photocycloaddition reactions. (a) First use of...
Scheme 29: Bifunctional hydrogen bonding/photocatalysed deracemisation of allenes.
Scheme 30: Bifunctional hydrogen bonding/photocatalysed deracemisation reactions. (a) Deracemisation of sulfox...
Scheme 31: Bifunctional hydrogen bonding/photocatalysed intramolecular [2 + 2] photocycloaddition of coumarins....
Scheme 32: Bifunctional hydrogen bonding/photocatalysed [2 + 2] photocycloadditions of quinolones. (a) Intramo...
Scheme 33: Hydrogen bonding/photocatalysed formal arylation of benzofuranones.
Scheme 34: Hydrogen bonding/photoredox-catalysed dehalogenative protonation of α,α-chlorofluoro ketones.
Scheme 35: Hydrogen bonding/photoredox-catalysed reductions. (a) Reduction of 1,2-diketones. (b) Reduction of ...
Scheme 36: Hydrogen bonding/HAT/photocatalysed deracemisation of cyclic ureas.
Scheme 37: Hydrogen bonding/HAT/photoredox-catalysed synthesis of cyclic sulfonamides.
Scheme 38: Hydrogen bonding/photoredox-catalysed reaction between imines and indoles.
Scheme 39: Chiral cation/photoredox-catalysed radical coupling of two α-amino radicals.
Scheme 40: Chiral phosphate/photoredox-catalysed hydroetherfication of alkenols.
Scheme 41: Chiral phosphate/photoredox-catalysed synthesis of pyrroloindolines.
Scheme 42: Chiral anion/photoredox-catalysed radical cation Diels–Alder reaction.
Scheme 43: Lewis acid/photoredox-catalysed cycloadditions of carbonyls. (a) Formal [2 + 2] cycloaddition of en...
Scheme 44: Lewis acid/photoredox-catalysed RCA reaction using a scandium Lewis acid between α-amino radicals a...
Scheme 45: Lewis acid/photoredox-catalysed RCA reaction using a copper Lewis acid between α-amino radicals and...
Scheme 46: Lewis acid/photoredox-catalysed synthesis of 1,2-amino alcohols from aldehydes and nitrones using a...
Scheme 47: Lewis acid/photocatalysed [2 + 2] photocycloadditions of enones and alkenes.
Scheme 48: Meggers’s chiral-at-metal catalysts.
Scheme 49: Lewis acid/photoredox-catalysed α-functionalisation of ketones with alkyl bromides bearing electron...
Scheme 50: Bifunctional Lewis acid/photoredox-catalysed radical coupling reaction using α-chloroketones and α-...
Scheme 51: Lewis acid/photocatalysed RCA of enones. (a) Using aldehydes as acyl radical precursors. (b) Other ...
Scheme 52: Bifunctional Lewis acid/photocatalysis for a photocycloaddition of enones.
Scheme 53: Lewis acid/photoredox-catalysed RCA reactions of enones using DHPs as radical precursors.
Scheme 54: Lewis acid/photoredox-catalysed functionalisation of β-ketoesters. (a) Hydroxylation reaction catal...
Scheme 55: Bifunctional copper-photocatalysed alkylation of imines.
Scheme 56: Copper/photocatalysed alkylation of imines. (a) Bifunctional copper catalysis using α-silyl amines....
Scheme 57: Bifunctional Lewis acid/photocatalysed intramolecular [2 + 2] photocycloaddition.
Scheme 58: Bifunctional Lewis acid/photocatalysed [2 + 2] photocycloadditions (a) Intramolecular cycloaddition...
Scheme 59: Bifunctional Lewis acid/photocatalysed rearrangement of 2,4-dieneones.
Scheme 60: Lewis acid/photocatalysed [2 + 2] cycloadditions of cinnamate esters and styrenes.
Scheme 61: Nickel/photoredox-catalysed arylation of α-amino acids using aryl bromides.
Scheme 62: Nickel/photoredox catalysis. (a) Desymmetrisation of cyclic meso-anhydrides using benzyl trifluorob...
Scheme 63: Nickel/photoredox catalysis for the acyl-carbamoylation of alkenes with aldehydes using TBADT as a ...
Scheme 64: Bifunctional copper/photoredox-catalysed C–N coupling between α-chloro amides and carbazoles or ind...
Scheme 65: Bifunctional copper/photoredox-catalysed difunctionalisation of alkenes with alkynes and alkyl or a...
Scheme 66: Copper/photoredox-catalysed decarboxylative cyanation of benzyl phthalimide esters.
Scheme 67: Copper/photoredox-catalysed cyanation reactions using TMSCN. (a) Propargylic cyanation (b) Ring ope...
Scheme 68: Palladium/photoredox-catalysed allylic alkylation reactions. (a) Using alkyl DHPs as radical precur...
Scheme 69: Manganese/photoredox-catalysed epoxidation of terminal alkenes.
Scheme 70: Chromium/photoredox-catalysed allylation of aldehydes.
Scheme 71: Enzyme/photoredox-catalysed dehalogenation of halolactones.
Scheme 72: Enzyme/photoredox-catalysed dehalogenative cyclisation.
Scheme 73: Enzyme/photoredox-catalysed reduction of cyclic imines.
Scheme 74: Enzyme/photocatalysed enantioselective reduction of electron-deficient alkenes as mixtures of (E)/(Z...
Scheme 75: Enzyme/photoredox catalysis. (a) Deacetoxylation of cyclic ketones. (b) Reduction of heteroaromatic...
Scheme 76: Enzyme/photoredox-catalysed synthesis of indole-3-ones from 2-arylindoles.
Scheme 77: Enzyme/HAT/photoredox catalysis for the DKR of primary amines.
Scheme 78: Bifunctional enzyme/photoredox-catalysed benzylic C–H hydroxylation of trifluoromethylated arenes.
Beilstein J. Org. Chem. 2020, 16, 1617–1626, doi:10.3762/bjoc.16.134
Graphical Abstract
Figure 1: The Arg–Gly–Asp tripeptide sequence and examples of tetrahydro-1,8-naphthyridine-containing integri...
Scheme 1: Commonly used synthetic routes to tetrahydro-1,8-naphthyridine moieties by hydrogenation of saturat...
Scheme 2: Previous synthetic route to fluoropyrrolidine 6 utilising a Wittig reaction and the novel, higher y...
Scheme 3: Synthesis of phosphoramidate 9 from tetrahydro-1,8-naphthyridine 8. Conditions: s-BuLi (3 equiv), d...
Scheme 4: Mono- and diphosphorylation of tetrahydro-1,8-naphthyridine 11. Conditions: (i) s-BuLi (2 equiv), d...
Scheme 5: Synthesis of amine 6 from phosphonate 7 and aldehyde 5. Conditions: (i) T3P® (50% w/w in DCM, 3 equ...
Scheme 6: Monodeuteration of 13 as observed by 1H and 13C NMR. Conditions: s-BuLi (3 equiv), THF, −42 °C, 20 ...
Scheme 7: Sequential diphosphorylation of tetrahydronaphthyridine 11. Conditions: (i) iPrMgCl (1.5 equiv), TH...
Scheme 8: Possible mechanistic pathways for the formation of dimer 28. Conditions: KOt-Bu, THF, 1 h, 68% yiel...
Scheme 9: Alkylation of phosphoramidate 13 by iodide 29 to afford compound 30 and byproducts alcohol 31 and d...
Beilstein J. Org. Chem. 2018, 14, 2646–2650, doi:10.3762/bjoc.14.242
Graphical Abstract
Figure 1: NDH-2 is a validated target for 1 with an MIC of 1.1 µg/mL against M. tuberculosis.
Scheme 1: Synthesis of phenothiazine-PEG-amine component.
Scheme 2: Synthesis of the azotochelin siderophore component.
Scheme 3: Final conjugation and deprotection to yield a phenothiazine siderophore conjugate.
Beilstein J. Org. Chem. 2018, 14, 2602–2606, doi:10.3762/bjoc.14.238
Graphical Abstract
Scheme 1: Preparation of α-C-acylated β-enamino amides 3 and 4. Reagents and conditions: 2, NMM, EtOCOCl, CH2...
Scheme 2: Domino fragmentation of 3 to β-keto amides 5 with competing cyclisation to pyrrolin-4-ones 6. Reage...
Scheme 3: Proposed mechanism for the formation of side products 6.
Scheme 4: Proposed mechanism for the formation of the target β-keto amides 5.
Scheme 5: Reactivity of analogues 9, lacking the auxiliary amino group [34].
Scheme 6: Domino fragmentation of compounds 4 (R2 = R3 = H) to N-protected ω-amino-β-keto amides 11.
Scheme 7: Ring–chain tautomerism in compounds 11b,c,f,j (n = 2) and reduction to the corresponding β-hydroxy ...
Beilstein J. Org. Chem. 2016, 12, 2849–2864, doi:10.3762/bjoc.12.284
Graphical Abstract
Figure 1: (a) Schematic representation of the biosynthesis of A47934 by the heterotetrameric non-ribosomal pe...
Figure 2: (a) Spectral analysis of StaF, showing the absorption spectra of ferric protein (red), ferrous prot...
Figure 3: Complete workflow for the Cytochrome P450 activity assay used in this study. 1) Loading of the subs...
Figure 4: (a) StaF activity against different peptide substrates and using NRPS constructs; the activity of S...
Figure 5: Structural analysis of StaF: (A) overall structure of StaF, with the heme moiety depicted using sti...
Figure 6: Sequence alignment of StaF and OxyAtei. Protein secondary structure was derived from the StaF cryst...
Figure 7: Sequence alignment of the A47934 (sta) and teicoplanin (tei) X-domain; secondary structure was deri...
Beilstein J. Org. Chem. 2016, 12, 444–461, doi:10.3762/bjoc.12.47
Graphical Abstract
Scheme 1: Breslow’s proposal on the mechanism of the benzoin condensation.
Scheme 2: Imidazolium carbene-catalysed homo-benzoin condensation.
Scheme 3: Homo-benzoin condensation in aqueous medium.
Scheme 4: Homobenzoin condensation catalysed by bis(benzimidazolium) salt 8.
Scheme 5: List of assorted chiral NHC-catalysts used for asymmetric homobenzoin condensation.
Scheme 6: A rigid bicyclic triazole precatalyst 15 in an efficient enantioselective benzoin reaction.
Scheme 7: Inoue’s report of cross-benzoin reactions.
Scheme 8: Cross-benzoin reactions catalysed by thiazolium salt 17.
Scheme 9: Catalyst-controlled divergence in cross-benzoin reactions.
Scheme 10: Chemoselective cross-benzoin reactions catalysed by a bulky NHC.
Scheme 11: Selective intermolecular cross-benzoin condensation reactions of aromatic and aliphatic aldehydes.
Scheme 12: Chemoselective cross-benzoin reaction of aliphatic and aromatic aldehydes.
Scheme 13: Cross-benzoin reactions of trifluoromethyl ketones developed by Enders.
Scheme 14: Cross-benzoin reactions of aldehydes and α-ketoesters.
Scheme 15: Enantioselective cross-benzoin reactions of aliphatic aldehydes and α-ketoesters.
Scheme 16: Dynamic kinetic resolution of β-halo-α-ketoesters via cross-benzoin reaction.
Scheme 17: Enantioselective benzoin reaction of aldehydes and alkynones.
Scheme 18: Aza-benzoin reaction of aldehydes and acylimines.
Scheme 19: NHC-catalysed diastereoselective synthesis of cis-2-amino 3-hydroxyindanones.
Scheme 20: Cross-aza-benzoin reactions of aldehydes with aromatic imines.
Scheme 21: Enantioselective cross aza-benzoin reaction of aliphatic aldehydes with N-Boc-imines.
Scheme 22: Chemoselective cross aza-benzoin reaction of aldehydes with N-PMP-imino esters.
Scheme 23: NHC-catalysed coupling reaction of acylsilanes with imines.
Scheme 24: Thiazolium salt-mediated enantioselective cross-aza-benzoin reaction.
Scheme 25: Aza-benzoin reaction of enals with activated ketimines.
Scheme 26: Isatin derived ketimines as electrophiles in cross aza-benzoin reaction with enals.
Scheme 27: Aza-benzoin reaction of aldehydes and phosphinoylimines catalysed by the BAC-carbene.
Scheme 28: Nitrosoarenes as the electrophilic component in benzoin-initiated cascade reaction.
Scheme 29: One-pot synthesis of hydroxamic esters via aza-benzoin reaction.
Scheme 30: Cookson and Lane’s report of intramolecular benzoin condensation.
Scheme 31: Intramolecular cross-benzoin condensation between aldehyde and ketone moieties.
Scheme 32: Intramolecular crossed aldehyde-ketone benzoin reactions.
Scheme 33: Enantioselective intramolecular crossed aldehyde-ketone benzoin reaction.
Scheme 34: Chromanone synthesis via enantioselective intramolecular cross-benzoin reaction.
Scheme 35: Intramolecular cross-benzoin reaction of chalcones.
Scheme 36: Synthesis of bicyclic tertiary alcohols by intramolecular benzoin reaction.
Scheme 37: A multicatalytic Michael–benzoin cascade process for cyclopentanone synthesis.
Scheme 38: Enamine-NHC dual-catalytic, Michael–benzoin cascade reaction.
Scheme 39: Iminium-cross-benzoin cascade reaction of enals and β-oxo sulfones.
Scheme 40: Intramolecular benzoin condensation of carbohydrate-derived dialdehydes.
Scheme 41: Enantioselective intramolecular benzoin reactions of N-tethered keto-aldehydes.
Scheme 42: Asymmetric cross-benzoin reactions promoted by camphor-derived catalysts.
Scheme 43: NHC-Brønsted base co-catalysis in a benzoin–Michael–Michael cascade.
Scheme 44: Divergent catalytic dimerization of 2-formylcinnamates.
Scheme 45: One-pot, multicatalytic asymmetric synthesis of tetrahydrocarbazole derivatives.
Scheme 46: NHC-chiral secondary amine co-catalysis for the synthesis of complex spirocyclic scaffolds.
Beilstein J. Org. Chem. 2014, 10, 1114–1120, doi:10.3762/bjoc.10.110
Graphical Abstract
Figure 1: Glutamate receptor ligands.
Scheme 1: Proposed synthetic plan for the preparation of compound of type Ib.
Scheme 2: Synthesis of 3-azetidinone derivative 16.
Scheme 3: Synthetic routes to prepare target cyclopropyl derivatives 20. Reagents and conditions: a) (EtO)2PO...
Figure 2: Mechanism for the attack of the carbene intermediate to the olefin moiety 18.
Figure 3: Representation of the lowest energy conformation of each diastereoisomers.
Scheme 4: Synthesis of glutamate “frozen” analogues 4-carboxy-1-(ethoxycarbonyl)-5-azaspiro[2.3]hexane.
Beilstein J. Org. Chem. 2014, 10, 369–383, doi:10.3762/bjoc.10.35
Graphical Abstract
Figure 1: Natural products and other bioactive piperidine derivatives of type B.
Figure 2: Retrosynthetic analysis of piperidines B (X = OH or leaving group, PG = protecting group).
Scheme 1: Synthesis of the protected amino acids 2. (a) KOH for 1b. b) PG–X = Cbz–Cl (1a–c), Boc2O (1d).
Scheme 2: Synthesis of hydroxy ketones 7 (R = Me (a), Bn (b), Ph (c) and EtSMe (d); PG = Cbz (a–c), Boc (d)).
Scheme 3: Synthesis of amides 5e and 5f and ketone 7e.
Scheme 4: Synthesis of amino alcohols syn-9a–d and oxazolidinone 10a. (for 7a–c conditions A: H2 (1 atm), Pd/...
Scheme 5: Competition between the Michaelis–Arbuzow process and the desired cyclodehydration of amino alcohol...
Scheme 6: Initial synthesis of the trans-piperidinol 11a in diminished enantiopurity. aThe amino alcohol 9a o...
Scheme 7: Synthesis of trans-piperidinol 11a in excellent ee.
Scheme 8: Synthesis of L-733,060·HCl.
Beilstein J. Org. Chem. 2013, 9, 1781–1790, doi:10.3762/bjoc.9.207
Graphical Abstract
Scheme 1: Formation of gem-dibromoolefin 3 from the reaction of carbon tetrabromide and triphenylphosphine as...
Scheme 2: Formation of the triphenylphosphine monoliths.
Figure 1: a. An unfunctionalised triphenylphosphine monolith; b. Monolith after functionalisation with carbon...
Scheme 3: Functionalising the triphenylphosphine monolith to give the active Ramirez monolith using carbon te...
Scheme 4: Flow synthesis of gem-dibromoolefins using the functionalised triphenylphosphine monolith.
Scheme 5: Flow synthesis of bromides from the corresponding alcohols using the functionalised triphenylphosph...
Scheme 6: Mechanisms for the Ramirez and Appel reactions [41,59].
Beilstein J. Org. Chem. 2013, 9, 1383–1387, doi:10.3762/bjoc.9.154
Graphical Abstract
Figure 1: Marketed calcium-sensing receptor agonist cinacalcet (1), and CaSR antagonists Calhex 231 (2) and N...
Scheme 1: Strategy for assembling (R)-3 from fragments 4, 5 and 6. m-Ns = m-nitrobenzenesulfonyl.
Scheme 2: Synthesis of amine building block 6 by using Katritzky’s pyrylium chemistry [16].
Scheme 3: Synthesis of phenol 4 from commercially available aryl fluoride 13.
Scheme 4: Synthesis of rac-3 and (R)-3 from commercially available racemic- and (S)-glycidol 15, respectively...
Figure 2: Determination of the optical purity for (R)-3 by chiral HPLC on a Daicel AD-H column. Top: Opticall...
Figure 3: Characterisation of concentration-dependent (R)-3 inhibition of 3.5 mM calcium-stimulated IP1 respo...
Beilstein J. Org. Chem. 2012, 8, 433–440, doi:10.3762/bjoc.8.49
Graphical Abstract
Scheme 1: Synthesis of cyclic sulfonium ylides 2; n = 0–3.
Scheme 2: Non-carbenoid formation of sulfonium ylide 4.
Scheme 3: Conditions: (a) phthalic anhydride, NEt3 (10 mol %), toluene, reflux, 2 h; (b) 1. carbonyldiimidazo...
Scheme 4: Rh(II)-catalysed carbenoid reactions of diazoesters 8a,b.
Figure 1: Proposed relative configurations of the diastereomeric cyclic sulfonium ylides 12aA and 12aB. 1H NM...
Scheme 5: Endo transition state for [3 + 3]-dimerisation of carbonyl ylide 14.
Scheme 6: Rh(II)-catalysed carbenoid reactions of diazoester 8c.
Scheme 7: Tandem cyclisation/intermolecular cycloaddition of diazoester 8a. Conditions: (a) Rh2(OAc)4 (3 mol ...
Scheme 8: Carbenoid formation of sulfonium ylides from diazoesters 11a,b. Conditions: (a) Rh2(OAc)4 (3 mol %)...
Beilstein J. Org. Chem. 2011, 7, 1327–1333, doi:10.3762/bjoc.7.156
Graphical Abstract
Scheme 1: Desymmetrising metallation for the enantioselective synthesis of atropisomers.
Scheme 2: Benzylic lithiation of a diaryl ether.
Scheme 3: Benzylic metallation of a diaryl ether α to a carbamate.
Scheme 4: Diastereo- and enantioselective synthesis of atropisomeric ethers by benzylic lithiation.
Scheme 5: Atroposelective stannylation.
Scheme 6: Stereospecific tin–lithium exchange/quench reactions.
Scheme 7: Proposed stereochemical pathway.
Beilstein J. Org. Chem. 2011, 7, 582–595, doi:10.3762/bjoc.7.68
Graphical Abstract
Figure 1: Seven out of the ten top selling drugs in the USA in 2009 contain sulfur. Figures in italics are to...
Figure 2: Naturally occurring organosulfur compounds glutathione and (R)-thioterpineol.
Figure 3: Methods for the synthesis of chiral tertiary thiol 1.
Scheme 1: Preparation of thioethers 4 from α-hydroxy esters.
Scheme 2: Nucleophilic substitution in α-aryl-α-hydroxy esters.
Scheme 3: Preparation of α,α-dialkylthioethers.
Scheme 4: Preparation of α-cyanothioacetate 12.
Scheme 5: Synthesis of (R)-(+)-spirobrassinin.
Scheme 6: Opening of cyclic sulfamidates with thiol nucleophiles.
Scheme 7: Synthesis of androgen 20.
Scheme 8: Synthesis of (+)-BE-52440A.
Scheme 9: The Mitsunobu reaction.
Scheme 10: Mitsunobu substitution at a quaternary centre.
Figure 4: Initially assigned structure of hexacyclinol.
Scheme 11: Preparation of thioether 29.
Scheme 12: Thioethers 33 prepared from phosphinites 31.
Scheme 13: Preparation of enantiomerically pure thiol 39.
Scheme 14: Thioethers prepared by a modified Mitsunobu reaction.
Scheme 15: Nucleophilic conjugate addition.
Scheme 16: Asymmetric addition to cyclic enones.
Scheme 17: Preparation of thioether 45.
Scheme 18: Catalytic kinetic resolution of the enantiomers of enone 46.
Scheme 19: Organocatalytic conjugate addition to nitroalkenes 49.
Scheme 20: Preparation of β-amino acid 54.
Scheme 21: Sulfur migration within oxazolidine-2-thiones 56.
Scheme 22: Preparation of thiols 62 by self-regeneration of stereocentres.
Scheme 23: Synthesis of (5R)-thiolactomycin.
Scheme 24: Preparation of tertiary thiols and thioethers via α-thioorganolithiums.
Scheme 25: Diastereoselective methylation of organolithium 71.
Scheme 26: Addition to lithiated thiocarbamate 75.
Scheme 27: Configurational lability in unhindered α-lithiothiocarbamates.
Scheme 28: Configurational stability in bulky α-lithiothiocarbamates.
Scheme 29: Asymmetric functionalisation of secondary benzylic thiocarbamates.
Scheme 30: Methylation of lithioallyl thiocarbamates.
Scheme 31: Asymmetric preparation of tertiary allylic thiols.
Scheme 32: Asymmetric preparation of thiols 96 by aryl migration in lithiated thiocarbamates.
Beilstein J. Org. Chem. 2011, 7, 442–495, doi:10.3762/bjoc.7.57
Graphical Abstract
Figure 1: Structures of atorvastatin and other commercial statins.
Figure 2: Structure of compactin.
Scheme 1: Synthesis of pentasubstituted pyrroles.
Scheme 2: [3 + 2] Cycloaddition to prepare 5-isopropylpyrroles.
Scheme 3: Regiospecific [3 + 2] cycloaddition to prepare the pyrrole scaffold.
Scheme 4: Formation of the pyrrole core of atorvastatin via [3 + 2] cycloaddition.
Scheme 5: Formation of pyrrole 33 via the Paal–Knorr reaction.
Scheme 6: Convergent synthesis towards atorvastatin.
Figure 3: Binding pocket of sunitinib in the TRK KIT.
Scheme 7: Synthesis of sunitinib.
Scheme 8: Alternative synthesis of sunitinib.
Scheme 9: Key steps in the syntheses of sumatriptan and zolmitriptan.
Scheme 10: Introduction of the N,N-dimethylaminoethyl side chain.
Scheme 11: Japp–Klingemann reaction in the synthesis of sumatriptan.
Scheme 12: Synthesis of the intermediate sulfonyl chlorides 62 and 63.
Scheme 13: Alternative introduction of the sulfonamide.
Scheme 14: Negishi-type coupling to benzylic sulfonamides.
Scheme 15: Heck reaction used to introduce the sulfonamide side chain of naratriptan.
Scheme 16: Synthesis of the oxazolinone appendage of zolmitriptan.
Scheme 17: Grandberg indole synthesis used in the preparation of rizatriptan.
Scheme 18: Improved synthesis of rizatriptan.
Scheme 19: Larock-type synthesis of rizatriptan.
Scheme 20: Synthesis of eletriptan.
Scheme 21: Heck coupling for the indole system in eletriptan.
Scheme 22: Attempted Fischer indole synthesis of elatriptan.
Scheme 23: Successful Fischer indole synthesis for eletriptan.
Scheme 24: Mechanistic rationale for the Bischler–Möhlau reaction.
Scheme 25: Bischler-type indole synthesis used in the fluvastatin sodium synthesis.
Scheme 26: Palladium-mediated synthesis of ondansetron.
Scheme 27: Fischer indole synthesis of ondansetron.
Scheme 28: Optimised Pictet–Spengler reaction towards tadalafil.
Figure 4: Structures of carvedilol 136 and propranolol 137.
Scheme 29: Synthesis of the carbazole core of carvedilol.
Scheme 30: Alternative syntheses of 4-hydroxy-9H-carbazole.
Scheme 31: Convergent synthesis of etodolac.
Scheme 32: Alternative synthesis of etodolac.
Figure 5: Structures of imidazole-containing drugs.
Scheme 33: Synthesis of functionalised imidazoles towards losartan.
Scheme 34: Direct synthesis of the chlorinated imidazole in losartan.
Scheme 35: Synthesis of trisubstituted imidazoles.
Scheme 36: Preparation of the imidazole ring in olmesartan.
Scheme 37: Synthesis of ondansetron.
Scheme 38: Alternative route to ondansetron and its analogues.
Scheme 39: Proton pump inhibitors and synthesis of esomeprazole.
Scheme 40: Synthesis of benzimidazole core pantoprazole.
Figure 6: Structure of rabeprazole 194.
Scheme 41: Synthesis of candesartan.
Scheme 42: Alternative access to the candesartan key intermediate 216.
Scheme 43: .Medicinal chemistry route to telmisartan.
Scheme 44: Improved synthesis of telmisartan.
Scheme 45: Synthesis of zolpidem.
Scheme 46: Copper-catalysed 3-component coupling towards zolpidem.
Figure 7: Structure of celecoxib.
Scheme 47: Preparation of celecoxib.
Scheme 48: Alternative synthesis of celecoxib.
Scheme 49: Regioselective access to celecoxib.
Scheme 50: Synthesis of pazopanib.
Scheme 51: Syntheses of anastrozole, rizatriptan and letrozole.
Scheme 52: Regioselective synthesis of anastrozole.
Scheme 53: Triazine-mediated triazole formation towards anastrozole.
Scheme 54: Alternative routes to 1,2,4-triazoles.
Scheme 55: Initial synthetic route to sitagliptin.
Figure 8: Binding of sitagliptin within DPP-IV.
Scheme 56: The process route to sitagliptin key intermediate 280.
Scheme 57: Synthesis of maraviroc.
Scheme 58: Synthesis of alprazolam.
Scheme 59: The use of N-nitrosoamidine derivatives in the preparation of fused benzodiazepines.
Figure 9: Structures of itraconazole, ravuconazole and voriconazole.
Scheme 60: Synthesis of itraconazole.
Scheme 61: Synthesis of rufinamide.
Scheme 62: Representative tetrazole formation in valsartan.
Figure 10: Structure of tetrazole containing olmesartan, candesartan and irbesartan.
Scheme 63: Early stage introduction of the tetrazole in losartan.
Scheme 64: Synthesis of cilostazol.
Figure 11: Structure of cefdinir.
Scheme 65: Semi-synthesis of cefdinir.
Scheme 66: Thiazole syntheses towards ritonavir.
Scheme 67: Synthesis towards pramipexole.
Scheme 68: Alternative route to pramipexole.
Scheme 69: Synthesis of famotidine.
Scheme 70: Efficient synthesis of the hyperuricemic febuxostat.
Scheme 71: Synthesis of ziprasidone.
Figure 12: Structure of mometasone.
Scheme 72: Industrial access to 2-furoic acid present in mometasone.
Scheme 73: Synthesis of ranitidine from furfuryl alcohol.
Scheme 74: Synthesis of nitrofurantoin.
Scheme 75: Synthesis of benzofuran.
Scheme 76: Synthesis of amiodarone.
Scheme 77: Synthesis of raloxifene.
Scheme 78: Alternative access to the benzo[b]thiophene core of raloxifene.
Scheme 79: Gewald reaction in the synthesis of olanzapine.
Scheme 80: Alternative synthesis of olanzapine.
Figure 13: Access to simple thiophene-containing drugs.
Scheme 81: Synthesis of clopidogrel.
Scheme 82: Pictet–Spengler reaction in the preparation of tetrahydrothieno[3,2-c]pyridine (422).
Scheme 83: Alternative synthesis of key intermediate 422.
Figure 14: Co-crystal structures of timolol (left) and carazolol (right) in the β-adrenergic receptor.
Scheme 84: Synthesis of timolol.
Scheme 85: Synthesis of tizanidine 440.
Scheme 86: Synthesis of leflunomide.
Scheme 87: Synthesis of sulfamethoxazole.
Scheme 88: Synthesis of risperidone.
Figure 15: Relative abundance of selected transformations.
Figure 16: The abundance of heterocycles within top 200 drugs (5-membered rings).
Beilstein J. Org. Chem. 2008, 4, No. 47, doi:10.3762/bjoc.4.47
Graphical Abstract
Scheme 1: Synthesis of racemic aldehydes.
Scheme 2: Diastereoisomeric imidazolidines and oxazolidines from biaryl aldehydes.
Figure 1: X-ray crystal structure of 9a. X-ray data has been deposited with the Cambridge Crystallographic Da...
Figure 2: X-ray crystal structure of 10a. X-ray data has been deposited with the Cambridge Crystallographic D...
Scheme 3: Atropisomeric alcohols by hydrolysis and reduction.
Scheme 4: Mechanistic rationalisation of the dynamic resolution in the formation of 9.
Beilstein J. Org. Chem. 2007, 3, No. 32, doi:10.1186/1860-5397-3-32
Graphical Abstract
Scheme 1: Allylsilane-N-acyliminium cyclisation.
Scheme 2: Enantioselective synthesis of (-)-indolizidine 167B by intramolecular allylsilane-N-acyliminium cyc...
Scheme 3: Synthesis of (±)-indolizidine 167B by intermolecular cyclisation of allylsilane-N-acyliminium cycli...
Scheme 4: Synthesis of 3,5-disubstituted indolizidines from L-pyroglutamic acid.
Scheme 5: Access to indolizidine precursors of dendroprimine starting from chiral 2-aminopropanoate.
Scheme 6: Access to (-)-dendroprimine by reduction with LiAlH4 of indolizidinones 26.
Scheme 7: Access to (-)-dendroprimine by catalytic hydrogenation of indolizidinones 26.
Scheme 8: Synthesis of (±)-myrtine and (±)-epimyrtine.
Scheme 9: Enantioselective synthesis of (+)-myrtine and (-)-epimyrtine.
Scheme 10: Synthesis of (±)-lasubines I and II and (±)-2-epilasubine II.
Scheme 11: Synthesis of (±)-lasubine I and II.
Scheme 12: Enantioselective synthesis of (-)-lasubines I and II and (+)-subcosine.